Transplant Monitoring Kits Market - Growth Drivers and Challenges
Growth Drivers
- Advancement in Technologies in Transplantation of Organs - In the United States, there are 104, 000 people on the transplant waiting list. In line with Donate Life America, 17 people are reportedly killed daily while waiting for a release. Organ donation has traditionally been a rite of passage for donors who pass away from brain death in a heartbeat. More donors who pass away after their hearts stop beating are receiving donated organs. Hearts and lungs from these deaths used to go unnecessarily in the past. These organs can now be used by transplant specialists thanks to modern medical advancements. To become a donor, transplant experts can resuscitate the heart using a heart-lung bypass device or an out-of-body perfusion device. These donors account for 20% to 30% of all organ donations. The heart attack diagnostics will also require most of the time transplantation.
- Rise in the Number of Organ Donors - According to preliminary information from the Organ Procurement and Transplantation Network, 42, 887 organ transplants were performed in the United States in 2022, an increase of 3.7 percent over 2021 and a new annual record. Several actions will be put in place today by the Region of the Americas 'health ministers to improve access to organ, tissue, and cell transplants. This initiative is based on voluntary donations to meet the growing need for these treatments, make these treatments more effective, save lives, and raise awareness of the need for them.
- Increasing Awareness Associating Transplantation - End-stage renal disease (ESRD) patients who receive living donor kidney transplantation (LDKT) have excellent and better graft survival than patients who have donor organs gone wrong. In many nations, healthy volunteers routinely donate organs to loved ones or family members, which represents a philosophical shift in clinical practice. It is recognized as morally acceptable and adheres to the agreed boundaries of best practice given that LDKT is becoming more prevalent worldwide and that healthcare professionals are committed to it by accepted standards and accepted best practices.
Challenges
- Lack of Organs to Donate Across the World - The liver transplant list currently addresses 12,240 Americans. Unfortunately, 25% of those patients will pass away while waiting. The American Liver Foundation (ALF) is working to raise awareness of living-donor liver transplants and reduce this statistic. The glaring reality of the world's organ shortage serves as a stark reminder of the difficulties that still exist in contemporary medicine in a world characterized by technological advancements and technological advancements. Organ donations have never been more necessary because millions of lives are in danger. The world's organ shortage is a sobering statistic. The demand for organ transplants far exceeds the supply, according to the World Health Organization (WHO), leading to a crisis that affects both patients and their families all over the world. Around 50,000 people pass away each year waiting for a suitable organ transplant.
- Excessive Cost of Organ Transplantation
- Sense of Fear in Patients Related to Organ Transplantation
Transplant Monitoring Kits Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
4.4% |
|
Base Year Market Size (2025) |
USD 5.66 billion |
|
Forecast Year Market Size (2035) |
USD 8.71 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of transplant monitoring kits is assessed at USD 5.88 billion.
The global transplant monitoring kits market size was valued at more than USD 5.66 billion in 2025 and is expected to register a CAGR of over 4.4%, exceeding USD 8.71 billion revenue by 2035.
North America is anticipated to secure nearly 41% share by 2035 in the transplant monitoring kits market, supported by rapid innovation in transplant monitoring technologies that is reshaping organ-delivery efficiency.
Key players in the market include CareDx Inc., Thermo Fisher Scientific, QIAGEN, Hologic, Eurofins Scientific, JETA Molecular, ELITech Group, Natera Inc., Roche Ltd., Biocare Health Resources Inc., Takeda Pharmaceutical Co Ltd., Astellas Pharma Inc., Otsuka Holdings Co Ltd., Eisai Co Ltd.